CYP2C19 polymorphism and clinical outcomes among patients of different races treated with clopidogrel: A systematic review and meta-analysis
- 16 April 2015
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Huazhong University of Science and Technology [Medical Sciences]
- Vol. 35 (2), 147-156
- https://doi.org/10.1007/s11596-015-1404-7
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Cytochrome CYP2C19 polymorphism and risk of adverse clinical events in clopidogrel-treated patients: A meta-analysis based on 23,035 subjectsArchives of Cardiovascular Diseases, 2013
- Clopidogrel: A Case for Indication-Specific PharmacogeneticsClinical Pharmacology & Therapeutics, 2012
- The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics studyEuropean Heart Journal, 2012
- The influence of CYP2C19*2 and *17 on on-treatment platelet reactivity and bleeding events in patients undergoing elective coronary stentingPharmacogenetics and Genomics, 2012
- Association of genetic variants in CYP2C19 and adverse clinical outcomes after treatment with clopidogrel: An updated meta-analysisThrombosis Research, 2011
- Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysisBMJ, 2011
- Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel TherapyJAMA, 2009
- Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort studyThe Lancet, 2009
- Coexisting Polymorphisms of P2Y12 and CYP2C19 Genes as a Risk Factor for Persistent Platelet Activation With ClopidogrelCirculation Journal, 2008
- Practical methods for incorporating summary time-to-event data into meta-analysisTrials, 2007